Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Comparing modalities for risk assessment in patients with pulmonary lesions and nondiagnostic bronchoscopy for suspected lung cancer

Fig. 1

Prevalence of malignancy in groups categorized as low risk (< 10%), intermediate risk (10–60%) and high risk (> 60%) by PAR and three risk models. Data is presented excluding cases that were considered nondiagnostic at 12 months follow up (Fig. 1a) and with nondiagnostic cases considered to be benign (Fig. 1b)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us